Stay updated with breaking news from Albert Bourla. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
2023 Sets Stage for Future Growth Potential: Completed Seagen Acquisition, Creating World-Class Oncology Organization; Launched Significant Number of New Products and Indications; and Realigned...
Pfizer's Q4 2023 financial report: adjusted EPS beats estimates at $0.10, FY2023 EPS down 72%, Q4 sales decline 41% to $14.25B. CEO's positive outlook and reaffirmed 2024 guidance.
Pfizer maintained its 2024 adjusted profit and sales forecasts of $2.05 to $2.25 per share earnings, and revenue of $58.5-billion to $61.5-billion
:quality(70)/cloudfront-eu-central-1.images.arcpublishing.com/irishtimes/3VI7G5HTSRDUCMYLV4L7X4U4UY.jpg)
Shares down 1.3% in morning trade after opening more than 2% higher
In 2023, Pfizer’s revenues grew 7% operationally, excluding contributions from Comirnaty and Paxlovid.